Literature DB >> 7053683

Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak.

L D Saravolatz, N Markowitz, L Arking, D Pohlod, E Fisher.   

Abstract

Infection with strains of methicillin-resistant Staphylococcus aureus occurred in 40 patients at time of admission to a large urban hospital from March to December 1980. Community-acquired methicillin-resistant S. aureus infections occurred in 24 drug abusers and 16 nonabusers. Patients with infections had a longer mean hospitalization and previously had received antimicrobial therapy more frequently than control subjects. Drug abusers with infections had been treated with cephalosporins more often than control subjects (P less than 0.05). Phage typing of 32 isolates showed that 21 were linked by a common phage type (29/52/80/95). Transmission of methicillin-resistant S. aureus from community-acquired cases occurred in the hospital. By January 1981, methicillin-resistant S. aureus accounted for 30.6% of nosocomial S. aureus infections at Henry Ford Hospital. Methicillin-resistant S. aureus infection may arise in the community as well as in the hospital and has the potential to disseminate in both settings.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053683     DOI: 10.7326/0003-4819-96-1-11

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  67 in total

1.  Skin and Soft Tissue Infections in Injection Drug Users.

Authors:  Patricia D. Brown; John R. Ebright
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

2.  Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada.

Authors:  John L Wylie; Deborah L Nowicki
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  The emergence of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in Canada.

Authors:  John M Conly; B Lynne Johnston
Journal:  Can J Infect Dis       Date:  2003-09

Review 4.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

Review 5.  Guarding against the most dangerous emerging pathogens.

Authors:  P W Ewald
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

6.  Impact of community-associated, methicillin-resistant Staphylococcus aureus on management of the skin and soft tissue infections in children.

Authors:  Kanokporn Mongkolrattanothai; Robert S Daum
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

7.  Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine.

Authors:  M H Levin; R A Weinstein; C Nathan; R K Selander; H Ochman; S A Kabins
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

8.  Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature.

Authors:  M A Gardam
Journal:  Can J Infect Dis       Date:  2000-07

9.  Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia.

Authors:  Tariq A Madani
Journal:  Can J Infect Dis       Date:  2002-07

10.  Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients.

Authors:  L Marty; A Flahault; B Suarez; J Caillon; C Hill; A Andremont
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.